Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for older heart patients.
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
February 14th is not only a day of love but also National Donor Day and one Chicopee couple has a special connection.
A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...
for the treatment of edema associated with congestive heart failure, as well as hepatic and renal disease. Bumetanide is a loop diuretic that is currently available as an oral and injectable therapy.
Iron deficiency may be linked to non-dialysis-dependent chronic kidney disease and mortality in patients without anemia, according to results of a nationwide cohort study. Overall, 27.2% of ...
According to a 2019 review, up to 84% of people with end stage chronic kidney disease develop pruritus. The authors state that recent advancements in dialysis treatments have helped bring the ...
The Abubakar Tafawa Balewa University Teaching Hospital, ATBUTH Bauchi, has cut down kidney dialysis prices by 70 per cent. Disclosing the development in a press release issued on Wednesday ...
Therefore, using new definitions for mode of death due to heart failure, we performed a retrospective chart review of records from a university-based heart failure disease management program to ...
Halevi said he is resigning in keeping with his promise since October 2023 that he would take responsibility for the October 7 failure. In a speech later Tuesday, the chief of staff called for a ...
The relationship between albuminuria and cardiovascular mortality and morbidity has been examined in 1,568 nonhypertensive, nondiabetic participants in the Framingham Heart Study. 28 A significant ...